Bensler’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8M Buy
21,497
+1,000
+5% +$1.02M 2.28% 12
2026
Q1
$18.9M Buy
20,497
+816
+4% +$827K 1.95% 13
2025
Q4
$21.2M Buy
19,681
+1,014
+5% +$970K 2.12% 11
2025
Q3
$14.2M Buy
18,667
+740
+4% +$551K 1.48% 22
2025
Q2
$14M Buy
17,927
+934
+5% +$726K 1.56% 23
2025
Q1
$14M Buy
16,993
+1,517
+10% +$1.26M 1.76% 18
2024
Q4
$11.9M Buy
15,476
+1,344
+10% +$1.11M 1.42% 22
2024
Q3
$12.5M Buy
14,132
+777
+6% +$699K 1.58% 19
2024
Q2
$12.1M Buy
13,355
+998
+8% +$798K 1.63% 19
2024
Q1
$9.61M Buy
12,357
+1,400
+13% +$996K 1.39% 24
2023
Q4
$6.39M Buy
10,957
+2,025
+23% +$1.18M 1.06% 32
2023
Q3
$4.8M Buy
8,932
+1,218
+16% +$628K 0.92% 40
2023
Q2
$3.62M Buy
7,714
+1,267
+20% +$531K 0.69% 48
2023
Q1
$2.21M Buy
+6,447
New +$2.17M 0.45% 71

Other funds holding LLY

Bensler's LLY Position: Q2 2026 in Review

Bensler increased its Eli Lilly (LLY) stake by 4.9% in Q2 2026, buying an estimated $1.02M and bringing the position to 21,497 shares worth $25.8M. The position accounts for 2.28% of the portfolio, ranked #12.

Bensler first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bensler held 21,497 shares of Eli Lilly worth $25.8M as of Q2 2026.
  • Bensler bought 1,000 Eli Lilly shares in Q2 2026, an estimated $1.02M.
  • Eli Lilly made up 2.28% of Bensler's portfolio in Q2 2026, its #12 holding.
  • Bensler first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bensler's 13F filing for Q2 2026, filed 23 Jul 2026.